Steve Duffy, Author at MPR
Steve Duffy

Steve Duffy

Digital Content Editor

All articles by Steve Duffy

NDA for Investigational Rosacea Treatment Submitted to FDA

Foamix Pharmaceuticals has submitted a New Drug Application (NDA) for FMX103, an investigational treatment for moderate to severe papulopustular rosacea in patients ≥18 years old. FMX103 is a topical foam formulation of minocycline. The NDA submission includes data from two phase 3 trials in which the efficacy and safety of the minocycline foam 1.5% was…